Litcius/Paper detail

Bifidobacterium longum subsp. longum 51A attenuates intestinal injury against irinotecan-induced mucositis in mice

Mônica F. Quintanilha, Vivian C. Miranda, Ramon O. Souza, Bruno Gallotti, Clênio Silva Cruz, Elândia A. Santos, Jacqueline I. Alvarez‐Leite, Luís Cláudio Lima de Jesus, Vasco Azevedo, Luísa Martins Trindade, Valbert Nascimento Cardoso, Ênio Ferreira, Bárbara Andrade de Carvalho, Pedro Marcos Gomes Soares, Angélica T. Vieira, Jacques R. Nicoli, Flaviano S. Martins

2021Life Sciences30 citationsDOI

Topics & Concepts

MucositisBifidobacterium longumProbioticIrinotecanPharmacologyBifidobacteriumIntestinal permeabilityIntestinal mucosaMedicineMicrobiologyImmunologyToxicityBiologyInternal medicineLactobacillusCancerColorectal cancerBacteriaGeneticsOral health in cancer treatmentCancer therapeutics and mechanismsNeutropenia and Cancer Infections
Bifidobacterium longum subsp. longum 51A attenuates intestinal injury against irinotecan-induced mucositis in mice | Litcius